Browsing Tag
Alfasigma
3 posts
GSK trades near 2,027p as Q1 core EPS rises 9%, full-year 2026 guidance reaffirmed
GSK beat the top line and held guidance, but the harder question is whether Specialty Medicines can keep outrunning the Vaccines and General Medicines drag.
GSK to sell linerixibat rights to Alfasigma for up to $690m as rare liver disease drug nears FDA approval
GSK and Alfasigma agree worldwide licence for linerixibat, a rare liver disease itch drug nearing FDA approval. Deal worth up to $690 million. Read more.
Alfasigma acquires IBS-C drug Zelnorm from Sloan Pharma
Alfasigma acquisition of Zelnorm : Alfasigma USA, a subsidiary of Italian pharmaceutical company Alfasigma, has acquired IBS-C drug…